Clinical Trials Directory

Trials / Completed

CompletedNCT05697887

Feasibility, Tolerability and Efficacy of the Ketogenic Diet in Children With Drug-resistant Epilepsy in South Vietnam

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
45 (actual)
Sponsor
Number 2 Children's Hospital, Ho Chi Minh City · Academic / Other
Sex
All
Age
1 Year – 10 Years
Healthy volunteers
Not accepted

Summary

According to the World Health Organization, more than 50 million people have epilepsy. Among them, nearly 80% of epileptic patients live in developing countries and 75% of them do not have access to treatment. The ketogenic diet (KD) has been shown as an effective alternative for patients with drug-resistant epilepsy. Although it has been studied by few studies in Asia, no such studies have been conducted in Vietnam. The purpose of this study was to verify the feasibility, tolerability, and efficacy of the KD in children with refractory epilepsies followed at a pediatric center in South Vietnam.

Detailed description

Children with drug-resistant epilepsy followed at Children's Hospital No.2, Viet Nam treated by KD were included in a prospective study from June 2019 to October 2021. Side-effects, retention rate, number, and duration of seizures were recorded after 1, 3, 6, 9, and 12 months of KD. Patients were considered as responders when a 50% seizure frequency was reached. Tolerance and acceptability of the KD were closely monitored.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTKetogenic dietThe ketogenic diet (KD) has been shown as an effective alternative for patients with drug-resistant epilepsy

Timeline

Start date
2019-06-01
Primary completion
2021-10-31
Completion
2021-10-31
First posted
2023-01-26
Last updated
2023-01-26

Locations

1 site across 1 country: Vietnam

Source: ClinicalTrials.gov record NCT05697887. Inclusion in this directory is not an endorsement.